effects [qlco]
Combination [qlco]
Perindopril [orch, phsu]
Indapamide [orch, phsu]
Calcium Channel [aapp, bacs]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Action [ftcn]
Diabetes [dsyn]
Vascular disease [dsyn]
Preterax [orch, phsu]
Diamicron [orch, phsu]
Controlled [ftcn]
Evaluation [ftcn]
Advance [medd]
Trial [resa]
Objective [inpr]
Present [qnco]
effects [qlco]
Fixed [fndg]
Combination [qlco]
Perindopril [orch, phsu]
Indapamide [orch, phsu]
Combination [qlco]
Calcium Channel Blockers [phsu]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Action [ftcn]
Diabetes [dsyn]
Vascular disease [dsyn]
Preterax [orch, phsu]
Diamicron [orch, phsu]
Controlled [ftcn]
Evaluation [ftcn]
Advance [medd]
Trial [resa]
FACTORIAL [resa]
randomized controlled trial [inpr, resa]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Assigned [ftcn]
Fixed [fndg]
Combination [qlco]
Perindopril+indapamide [orch, phsu]
mg% [qnco]
placebo [topp]
effects [qlco]
randomized [resa]
treatment [ftcn]
Mortality [qnco]
CARDIOVASCULAR [bdsy]
Examined [fndg]
subgroups [virs]
Defined [cnce]
baseline [bodm]
Calcium Channel Blockers [phsu]
Patients [podg]
baseline [bodm]
N NOS [aapp, imft]
high-risk group [popg]
Compared [acty]
N NOS [aapp, imft]
Extensive [qlco]
Antihypertensive [phsu]
Therapies [topp]
Active Treatment [topp]
Reduced [qlco]
Relative Risk [qnco]
Patients [podg]
baseline [bodm]
Compared [acty]
Without [qlco]
P NOS [aapp, imft]
Homogeneity [qlco]
Whole [qnco]
Relative Risk [qnco]
reduction [npop]
cardiovascular events [fndg]
With [qlco]
baseline [bodm]
Not significant [fndg]
Statistically [ocdi]
P NOS [aapp, imft]
Homogeneity [qlco]
adverse effects [ftcn]
Receive [qlco]
Combination [qlco]
Perindopril [orch, phsu]
Indapamide [orch, phsu]
Calcium Channel Blockers [phsu]
Protection [fndg]
Mortality [qnco]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
